FR2883179B1 - Comprime enrobe - Google Patents

Comprime enrobe

Info

Publication number
FR2883179B1
FR2883179B1 FR0502727A FR0502727A FR2883179B1 FR 2883179 B1 FR2883179 B1 FR 2883179B1 FR 0502727 A FR0502727 A FR 0502727A FR 0502727 A FR0502727 A FR 0502727A FR 2883179 B1 FR2883179 B1 FR 2883179B1
Authority
FR
France
Prior art keywords
coated tablet
fentanyl
preparation
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0502727A
Other languages
English (en)
Other versions
FR2883179A1 (fr
Inventor
Pascal Oury
Guillaume Benoist
Catherine Herry
Joseph Duvochel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0502727A priority Critical patent/FR2883179B1/fr
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Priority to NZ561154A priority patent/NZ561154A/en
Priority to PT06724230T priority patent/PT1858491E/pt
Priority to JP2008501248A priority patent/JP5138577B2/ja
Priority to CN2006800084725A priority patent/CN101141951B/zh
Priority to US11/384,763 priority patent/US8709479B2/en
Priority to BRPI0608505A priority patent/BRPI0608505B8/pt
Priority to ES06724230T priority patent/ES2365984T3/es
Priority to AU2006224690A priority patent/AU2006224690B2/en
Priority to RU2007138647/15A priority patent/RU2403043C2/ru
Priority to KR1020077021447A priority patent/KR101239926B1/ko
Priority to CA2599502A priority patent/CA2599502C/fr
Priority to PL06724230T priority patent/PL1858491T3/pl
Priority to PCT/EP2006/003304 priority patent/WO2006097361A1/fr
Priority to US11/909,057 priority patent/US20080226717A1/en
Priority to MX2007011440A priority patent/MX2007011440A/es
Priority to DK06724230.5T priority patent/DK1858491T3/da
Priority to UAA200710340A priority patent/UA88509C2/ru
Priority to EP06724230A priority patent/EP1858491B1/fr
Priority to SI200631068T priority patent/SI1858491T1/sl
Priority to DE602006021713T priority patent/DE602006021713D1/de
Priority to AT06724230T priority patent/ATE507824T1/de
Priority to ZA200707900A priority patent/ZA200707900B/xx
Publication of FR2883179A1 publication Critical patent/FR2883179A1/fr
Priority to IL185626A priority patent/IL185626A/en
Priority to NO20075345A priority patent/NO338771B1/no
Priority to HK08102157.7A priority patent/HK1109730A1/xx
Publication of FR2883179B1 publication Critical patent/FR2883179B1/fr
Application granted granted Critical
Priority to CY20111100746T priority patent/CY1111729T1/el
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
FR0502727A 2005-03-18 2005-03-18 Comprime enrobe Active FR2883179B1 (fr)

Priority Applications (27)

Application Number Priority Date Filing Date Title
FR0502727A FR2883179B1 (fr) 2005-03-18 2005-03-18 Comprime enrobe
UAA200710340A UA88509C2 (ru) 2005-03-18 2006-03-20 Сублингвальная таблетка с покрытием, которое содержит опиоидный анальгетик
MX2007011440A MX2007011440A (es) 2005-03-18 2006-03-20 Tableta recubierta sublingual.
CN2006800084725A CN101141951B (zh) 2005-03-18 2006-03-20 舌下包衣片
US11/384,763 US8709479B2 (en) 2005-03-18 2006-03-20 Sublingual coated tablet of fentanyl
BRPI0608505A BRPI0608505B8 (pt) 2005-03-18 2006-03-20 comprimido sublingual revestido
ES06724230T ES2365984T3 (es) 2005-03-18 2006-03-20 Comprimido recubierto sublingual.
AU2006224690A AU2006224690B2 (en) 2005-03-18 2006-03-20 Sublingual coated tablet
RU2007138647/15A RU2403043C2 (ru) 2005-03-18 2006-03-20 Подъязычная таблетка, покрытая оболочкой
KR1020077021447A KR101239926B1 (ko) 2005-03-18 2006-03-20 설하용 코팅정
CA2599502A CA2599502C (fr) 2005-03-18 2006-03-20 Comprime sublingual enrobe
PL06724230T PL1858491T3 (pl) 2005-03-18 2006-03-20 Podjęzykowa tabletka powlekana
PCT/EP2006/003304 WO2006097361A1 (fr) 2005-03-18 2006-03-20 Comprime sublingual enrobe
US11/909,057 US20080226717A1 (en) 2005-03-18 2006-03-20 Sublingual Coated Tablet
NZ561154A NZ561154A (en) 2005-03-18 2006-03-20 Sublingual coated tablet
JP2008501248A JP5138577B2 (ja) 2005-03-18 2006-03-20 舌下用被覆錠剤
DK06724230.5T DK1858491T3 (da) 2005-03-18 2006-03-20 Sublingual overtrukket tablet
EP06724230A EP1858491B1 (fr) 2005-03-18 2006-03-20 Comprime sublingual enrobe
SI200631068T SI1858491T1 (sl) 2005-03-18 2006-03-20 Sublingvalna obloĺ˝ena tableta
DE602006021713T DE602006021713D1 (de) 2005-03-18 2006-03-20 Sublinguales dragee
AT06724230T ATE507824T1 (de) 2005-03-18 2006-03-20 Sublinguales dragee
ZA200707900A ZA200707900B (en) 2005-03-18 2006-03-20 Sublingual coated tablet
PT06724230T PT1858491E (pt) 2005-03-18 2006-03-20 Comprimido sublingual revestido
IL185626A IL185626A (en) 2005-03-18 2007-08-30 A tablet is coated for the provision of a multilingual, process for its preparation and use
NO20075345A NO338771B1 (no) 2005-03-18 2007-10-18 Sublingual belagt tablett
HK08102157.7A HK1109730A1 (en) 2005-03-18 2008-02-27 Sublingual coated tablet
CY20111100746T CY1111729T1 (el) 2005-03-18 2011-08-03 Υπογλωσσιο επικαλυμμενο δισκιο

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0502727A FR2883179B1 (fr) 2005-03-18 2005-03-18 Comprime enrobe

Publications (2)

Publication Number Publication Date
FR2883179A1 FR2883179A1 (fr) 2006-09-22
FR2883179B1 true FR2883179B1 (fr) 2009-04-17

Family

ID=35309611

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0502727A Active FR2883179B1 (fr) 2005-03-18 2005-03-18 Comprime enrobe

Country Status (26)

Country Link
US (2) US8709479B2 (fr)
EP (1) EP1858491B1 (fr)
JP (1) JP5138577B2 (fr)
KR (1) KR101239926B1 (fr)
CN (1) CN101141951B (fr)
AT (1) ATE507824T1 (fr)
AU (1) AU2006224690B2 (fr)
BR (1) BRPI0608505B8 (fr)
CA (1) CA2599502C (fr)
CY (1) CY1111729T1 (fr)
DE (1) DE602006021713D1 (fr)
DK (1) DK1858491T3 (fr)
ES (1) ES2365984T3 (fr)
FR (1) FR2883179B1 (fr)
HK (1) HK1109730A1 (fr)
IL (1) IL185626A (fr)
MX (1) MX2007011440A (fr)
NO (1) NO338771B1 (fr)
NZ (1) NZ561154A (fr)
PL (1) PL1858491T3 (fr)
PT (1) PT1858491E (fr)
RU (1) RU2403043C2 (fr)
SI (1) SI1858491T1 (fr)
UA (1) UA88509C2 (fr)
WO (1) WO2006097361A1 (fr)
ZA (1) ZA200707900B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06007453A (es) * 2003-12-31 2007-01-31 Cima Labs Inc Forma de dosificacion de opiaceo oral efervescente.
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20090082466A1 (en) * 2006-01-27 2009-03-26 Najib Babul Abuse Resistant and Extended Release Formulations and Method of Use Thereof
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
CN101394863B (zh) * 2006-01-06 2016-12-21 阿塞尔Rx制药有限公司 小体积口腔经粘膜剂型
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
DE102006054638B4 (de) * 2006-11-16 2014-12-04 Laburnum Gmbh Pharmazeutische Einzeldosisform
KR101445891B1 (ko) * 2007-01-05 2014-10-02 아셀알엑스 파마슈티컬스 인코퍼레이티드 경구 경점막 제형의 투여를 위한 저장 및 분배 장치
US20100010031A1 (en) 2007-02-09 2010-01-14 Yum Ii Su Transoral dosage forms comprising sufentanil and naloxone
DK2182902T3 (en) * 2007-08-07 2015-04-13 Acelrx Pharmaceuticals Inc Compositions comprising sufentanil and triazolam for procedure sedation and analgesia using oral transmucosal dosage forms
FR2920308B1 (fr) * 2007-09-05 2011-02-25 Unither Dev Forme pharmaceutique pour l'administration par voie orale de principes actifs.
US20090196890A1 (en) * 2007-12-17 2009-08-06 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
US20090263476A1 (en) * 2008-04-16 2009-10-22 Jobdevairakkam Christopher N Composition of Rapid Disintegrating Direct Compression Buccal Tablet
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
CA2765033C (fr) 2009-06-12 2020-07-14 Meritage Pharma, Inc. Procedes de traitement de troubles gastro-intestinaux
EA025054B1 (ru) * 2009-06-12 2016-11-30 Сайнэпсус Терапьютикс, Инк. Единичная дозированная форма для сублингвального введения, включающая частицы апоморфина, для лечения болезни паркинсона или половой дисфункции
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
US20110288128A1 (en) * 2010-05-21 2011-11-24 Acelrx Pharmaceuticals, Inc. Oral Transmucosal Administration of Sufentanil
EP2455069A1 (fr) * 2010-11-11 2012-05-23 Laburnum GMBH Formule d'enrichissement sans agent actif, son procédé de fabrication et son utilisation
CN103327969A (zh) * 2010-12-23 2013-09-25 普渡制药公司 抗篡改固体口服剂型
US9763884B2 (en) * 2011-05-13 2017-09-19 Eb Ip Hybritabs B.V. Drug delivery system
EP3939569A1 (fr) 2011-09-19 2022-01-19 Orexo AB Nouvelle composition pharmaceutique résistant aux abus, pour le traitement de la dépendance aux opioïdes
LT2849730T (lt) 2012-05-02 2016-12-27 Orexo Ab Nauja alfentanilo kompozicija, skirta ūmaus skausmo gydymui
CN102755322B (zh) * 2012-07-24 2013-12-11 兆科药业（广州）有限公司 一种乐卡地平和阿托伐他汀复方制剂
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP2886103A1 (fr) * 2013-12-23 2015-06-24 Hexal AG Composition pharmaceutique orodispensible comprenant des particules de la buprénorphine avec une taille particulière
EP3169315B1 (fr) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus à libération immédiate
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
EP3578164A1 (fr) * 2018-06-05 2019-12-11 Bio-Gate AG Composition thixotrope
CN209673136U (zh) 2019-05-07 2019-11-22 深圳市华普森电子有限公司 高清智能一体化管道探测器

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621954A (fr) * 1961-09-10
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
FR2621483B1 (fr) * 1987-10-08 1991-09-20 Medibrevex Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CA2147862A1 (fr) * 1992-11-05 1994-05-11 Robert E. Dempski Dispositif de delivrance de medicaments
US5411745A (en) 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5744164A (en) 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
FR2771291B1 (fr) 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2769524B1 (fr) 1998-01-06 1999-12-31 Ethypharm Lab Prod Ethiques Dispositif d'enrobage pour granules a absorber par voie orale
FR2774910B1 (fr) 1998-02-16 2001-09-07 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6248760B1 (en) * 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
US20010016593A1 (en) * 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
FR2794646B1 (fr) 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
FR2796840B1 (fr) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6602518B2 (en) * 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
CA2456322A1 (fr) 2001-08-06 2003-02-20 Euro-Celtique, S.A. Compositions et methodes destinees a prevenir l'abus d'opioides
US20030191147A1 (en) 2002-04-09 2003-10-09 Barry Sherman Opioid antagonist compositions and dosage forms
ATE329594T1 (de) * 2003-01-31 2006-07-15 Orexo Ab Schnell wirkende pharmazeutische zusammensetzung
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe

Also Published As

Publication number Publication date
KR101239926B1 (ko) 2013-03-07
CA2599502C (fr) 2013-05-14
NO338771B1 (no) 2016-10-17
BRPI0608505A2 (pt) 2010-01-05
RU2403043C2 (ru) 2010-11-10
FR2883179A1 (fr) 2006-09-22
BRPI0608505B8 (pt) 2021-05-25
NZ561154A (en) 2010-12-24
RU2007138647A (ru) 2009-04-27
SI1858491T1 (sl) 2011-09-30
NO20075345L (no) 2007-12-17
WO2006097361A1 (fr) 2006-09-21
EP1858491B1 (fr) 2011-05-04
EP1858491A1 (fr) 2007-11-28
KR20070114756A (ko) 2007-12-04
BRPI0608505B1 (pt) 2021-05-04
AU2006224690A1 (en) 2006-09-21
US8709479B2 (en) 2014-04-29
US20080226717A1 (en) 2008-09-18
JP2008533084A (ja) 2008-08-21
US20060210632A1 (en) 2006-09-21
ATE507824T1 (de) 2011-05-15
CN101141951B (zh) 2011-02-09
PL1858491T3 (pl) 2012-03-30
PT1858491E (pt) 2011-08-18
DE602006021713D1 (de) 2011-06-16
CA2599502A1 (fr) 2006-09-21
CN101141951A (zh) 2008-03-12
JP5138577B2 (ja) 2013-02-06
DK1858491T3 (da) 2011-08-22
AU2006224690B2 (en) 2011-09-29
ZA200707900B (en) 2009-01-28
ES2365984T3 (es) 2011-10-14
IL185626A0 (en) 2008-01-06
MX2007011440A (es) 2007-11-14
UA88509C2 (ru) 2009-10-26
IL185626A (en) 2014-09-30
CY1111729T1 (el) 2015-10-07
HK1109730A1 (en) 2008-06-20

Similar Documents

Publication Publication Date Title
FR2883179B1 (fr) Comprime enrobe
AR114143A2 (es) Formulaciones de comprimidos revestidos
EA200802008A1 (ru) Фармацевтические композиции
DK1879623T3 (da) Genterapi til rygmarvssygdomme
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
BRPI0719398A2 (pt) Composição farmacêutica.
DK1871181T3 (da) Kosttilskud til HIV-patienter
DK1957073T3 (da) Lægemiddel
DK3072507T3 (da) Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
DE602007005372D1 (de) Zweischichtige tablette zur verhinderung von kardiovaskulären ereignissen
FR2900034B1 (fr) Poudrier.
DK2007384T3 (da) Orodispergerbare domperidontabletter
NO20091386L (no) Fenyloksyanilinderivater
ATE438381T1 (de) Zolpidemtabletten
DK2081944T3 (da) Nye morfin-derivater
DK1720557T3 (da) Hurtig-opløselig, smagsmaskeret tablet
DK2001445T3 (da) Farmaceutiske sfæroider
DK1962960T3 (da) Fremgangsmåde til mikornisering
DK1934388T3 (da) Fremgangsmåde til lægemiddeludvikling
EA201001401A1 (ru) Улучшенные изомальтитсодержащие таблетки и способ их изготовления
ITBO20060023U1 (it) Orecchino pendente.
ES1059640Y (es) Mantel con puntilla
UA10369S (uk) Таблетка фармацевтична
TH86391B (th) ต่างหู

Legal Events

Date Code Title Description
GC Lien (pledge) constituted

Effective date: 20140519

PLFP Fee payment

Year of fee payment: 11

GC Lien (pledge) constituted

Effective date: 20160120

PLFP Fee payment

Year of fee payment: 12

RG Lien (pledge) cancelled

Effective date: 20160226

PLFP Fee payment

Year of fee payment: 13

RG Lien (pledge) cancelled

Effective date: 20170418

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20